Skip to main content

Advertisement

Log in

Daily Intake of High-Fat Diet with Lysophosphatidic Acid-Rich Soybean Phospholipids Augments Colon Tumorigenesis in Kyoto Apc Delta Rats

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Oral administration of lysophosphatidic acid (LPA) was shown to attenuate gastric ulceration in rats and mice but aggravate intestinal tumorigenesis in mice.

Aims

The present study examined whether dietary LPA induces or prevents development of colorectal tumor in rats.

Methods

Kyoto Apc Delta rats fed high-fat diet with or without an LPA-rich soybean phospholipid mixture (LSP, 0.1 or 1%) were treated with azoxymethane and dextran sodium sulfate to induce colorectal tumorigenesis. Rats were killed 15 weeks after azoxymethane treatment, and size, total number, location, and severity of colorectal tumors were assessed. Expression of mRNA of LPA receptors in rat colon tissue was assayed.

Results

Rats fed the diet supplemented with 1% LSP had a higher number of tumors 2–4 mm long compared than those with or without 0.1% LSP. The mean distance of tumors >4 mm long from the anus was significantly higher than those of tumors <2 and 2–4 mm long in rats fed 1% LSP-supplemented diet. Supplementation of the diet with 0.1% LSP decreased mRNA expression of LPA5 in colon tumors of rats.

Conclusions

Dietary supplementation of LPA-rich phospholipids dose-dependently augmented colorectal tumorigenesis. Decreased expression of LPA5 in colon tumors may be relevant to augmented tumorigenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ACF:

Aberrant crypt foci

ATX:

Autotaxin

AOM:

Azoxymethane

Apc:

Adenomatous polyposis coli

DSS:

Dextran sodium sulfate

HF:

High-fat diet

KAD:

Kyoto Apc Delta

LPA:

Lysophosphatidic acid

LSP:

LPA-rich soybean phospholipid mixture

LPC:

Lysophosphatidylcholine

LPE:

Lysophosphatidylethanolamine

LPI:

Lysophosphatidylinositol

LPS:

Lysophosphatidylserine

TG:

Triglyceride

References

  1. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal; 2012. Accessed 03.10.2016.

  2. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525–2538.

    Article  CAS  PubMed  Google Scholar 

  3. Su LJ, Arab L. Alcohol consumption and risk of colon cancer: evidence from the national health and nutrition examination survey I epidemiologic follow-up study. Nutr Cancer. 2004;50:111–119.

    Article  PubMed  Google Scholar 

  4. Hooker CM, Gallicchio L, Genkinger JM, Comstock GW, Alberg AJ. A prospective cohort study of rectal cancer risk in relation to active cigarette smoking and passive smoke exposure. Ann Epidemiol. 2008;18:28–35.

    Article  PubMed  Google Scholar 

  5. Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer. Ann Oncol. 2012;23:491–500.

    Article  CAS  PubMed  Google Scholar 

  6. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE. 2013;8:e53916.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–659.

    Article  CAS  PubMed  Google Scholar 

  8. Romano M, De Francesco F, Zarantonello L, et al. From inflammation to cancer in inflammatory bowel disease: molecular perspectives. Anticancer Res. 2016;36:1447–1460.

    CAS  PubMed  Google Scholar 

  9. Yun CC, Kumar A. Diverse roles of LPA signaling in the intestinal epithelium. Exp Cell Res. 2015;333:201–207.

    Article  CAS  PubMed  Google Scholar 

  10. Lin S, Yeruva S, He P, et al. Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. Gastroenterology. 2010;138:649–658.

    Article  CAS  PubMed  Google Scholar 

  11. Lin S, Wang D, Iyer S, et al. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology. 2009;136:1711–1720.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fukui R, Tanabe E, Kitayoshi M, Yoshikawa K, Fukushima N, Tsujiuchi T. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells. Tumour Biol. 2012;33:1899–1905.

    Article  CAS  PubMed  Google Scholar 

  13. Tatsuta M, Iishi H, Baba M, et al. Induction by lysophosphatidic acid of peritoneal and pleural metastases of intestinal cancers induced by azoxymethane in Wistar rats. Cancer Lett. 2005;219:137–145.

    Article  CAS  PubMed  Google Scholar 

  14. Sturm A, Zeeh J, Sudermann T, Rath H, Gerken G, Dignass AU. Lisofylline and lysophospholipids ameliorate experimental colitis in rats. Digestion. 2002;66:23–29.

    Article  CAS  PubMed  Google Scholar 

  15. Lee SJ, Leoni G, Neumann PA, Chun J, Nusrat A, Yun CC. Distinct phospholipase C-beta isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol Cell Biol. 2013;33:2016–2028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Adachi M, Horiuchi G, Ikematsu N, et al. Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress. Dig Dis Sci. 2011;56:2252–2261.

    Article  CAS  PubMed  Google Scholar 

  17. Tanaka T, Morito K, Kinoshita M, et al. Orally administered phosphatidic acids and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice. Dig Dis Sci. 2013;58:950–958.

    Article  CAS  PubMed  Google Scholar 

  18. Tokumura A, Tominaga K, Yasuda K, Kanzaki H, Kogure K, Fukuzawa K. Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors. Cancer. 2002;94:141–151.

    Article  CAS  PubMed  Google Scholar 

  19. Tanaka T, Horiuchi G, Matsuoka M, et al. Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves. Biosci Biotechnol Biochem. 2009;73:1293–1300.

    Article  CAS  PubMed  Google Scholar 

  20. Kaffarnik S, Ehlers I, Grobner G, Schleucher J, Vetter W. Two-dimensional (3)(1)P, (1)H NMR spectroscopic profiling of phospholipids in cheese and fish. J Agric Food Chem. 2013;61:7061–7069.

    Article  CAS  PubMed  Google Scholar 

  21. Hwang SH, Shin TJ, Choi SH, et al. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol Cells. 2012;33:151–162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tayyem RF, Shehadah I, Abu-Mweis SS, et al. Fruit and vegetable intake among Jordanians: results from a case-control study of colorectal cancer. Cancer Control. 2014;21:350–360.

    PubMed  Google Scholar 

  23. Amos-Landgraf JM, Heijmans J, Wielenga MC, et al. Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones. Proc Natl Acad Sci USA. 2014;111:16514–16519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Amos-Landgraf JM, Kwong LN, Kendziorski CM, et al. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci USA. 2007;104:4036–4041.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Yoshimi K, Tanaka T, Takizawa A, et al. Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci. 2009;100:2022–2027.

    Article  CAS  PubMed  Google Scholar 

  26. Nilsson A, Borgstrom B. Absorption and metabolism of lecithin and lysolecithin by intestinal slices. Biochim Biophys Acta. 1967;137:240–254.

    Article  CAS  PubMed  Google Scholar 

  27. Inoue M, Adachi M, Shimizu Y, Tsutsumi T, Tokumura A. Comparison of lysophospholipid levels in rat feces with those in a standard chow. J Agric Food Chem. 2011;59:7062–7067.

    Article  CAS  PubMed  Google Scholar 

  28. Tsutsumi T, Yamakawa S, Ishihara A, Yamamoto A, Tanaka T, Tokumura A. Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: its possible protective role in renal fibrosis. Toxicol Rep. 2015;2:121–129.

    Article  CAS  Google Scholar 

  29. Borena W, Stocks T, Jonsson H, et al. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control. 2011;22:291–299.

    Article  PubMed  Google Scholar 

  30. Yang CM, Kendall CW, Stamp D, Medline A, Archer MC, Bruce WR. Thermally oxidized dietary fat and colon carcinogenesis in rodents. Nutr Cancer. 1998;30:69–73.

    Article  CAS  PubMed  Google Scholar 

  31. Warschkow R, Sulz MC, Marti L, et al. Better survival in right-sided versus left-sided stage I–III colon cancer patients. BMC Cancer. 2016;16:554.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schub R, Steinheber FU. Rightward shift of colon cancer. A feature of the aging gut. J Clin Gastroenterol. 1986;8:630–634.

    Article  CAS  PubMed  Google Scholar 

  33. Keune WJ, Hausmann J, Bolier R, et al. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling. Nat Commun. 2016;7:11248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Araki M, Kitayoshi M, Dong Y, et al. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells. Growth Factors. 2014;32:117–122.

    Article  CAS  PubMed  Google Scholar 

  35. Yap LF, Velapasamy S, Lee HM, et al. Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma. J Pathol. 2015;235:456–465.

    Article  CAS  PubMed  Google Scholar 

  36. Elzagheid A, Emaetig F, Alkikhia L, et al. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer. Anticancer Res. 2013;33:3137–3143.

    PubMed  Google Scholar 

  37. Kunzmann AT, Murray LJ, Cardwell CR, McShane CM, McMenamin UC, Cantwell MM. PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22:1490–1497.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Dr. Kenji Tsukigawa for tumor assessment, and Naoki Shirasaka for kindly providing a preparation of LPA-rich soybean phospholipid mixture.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshihiko Tsutsumi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsutsumi, T., Inoue, M., Okamoto, Y. et al. Daily Intake of High-Fat Diet with Lysophosphatidic Acid-Rich Soybean Phospholipids Augments Colon Tumorigenesis in Kyoto Apc Delta Rats. Dig Dis Sci 62, 669–677 (2017). https://doi.org/10.1007/s10620-016-4434-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4434-5

Keywords

Navigation